D-0573-2022 Class II Ongoing
FDA drug recall D-0573-2022 was initiated by RISING PHARMACEUTICALS on February 7, 2022 and is designated Class II. Reason for recall: Failed Tablet Specifications: Recall of this drug product was voluntarily initiated by the manufacturer due to a market complaint, which stated that a tablet in the sealed bottle was twice larger in s… The recall status is ongoing. Affected quantity: 2220 100-count bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- March 2, 2022
- Initiation Date
- February 7, 2022
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2220 100-count bottles
Product Description
Methylphenidate Hydrochloride Chewable Tablets, 2.5 mg, 100-count bottle, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., Saddle Brook, NJ 07863, NDC 64980-221-01
Reason for Recall
Failed Tablet Specifications: Recall of this drug product was voluntarily initiated by the manufacturer due to a market complaint, which stated that a tablet in the sealed bottle was twice larger in size when compared to the remaining tablets. This complaint is second of its kind.
Distribution Pattern
Nationwide in the USA
Code Information
lot# 25910009, Exp 01/2023